Kitta Takeya, Chancellor Michael B, de Groat William C, Kuno Sadako, Nonomura Katsuya, Yoshimura Naoki
Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Department of Renal and Genitourinary Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Neurourol Urodyn. 2014 Nov;33(8):1259-65. doi: 10.1002/nau.22487. Epub 2013 Sep 9.
Adenosine is a neurotransmitter that exerts numerous physiological effects in many organs. However, few studies have focused on the role of adenosine receptors in the control of micturition. Therefore, we examined the role of adenosine A1 and A2A receptors in the control of bladder activity in rats with normal or acetic acid (AA) irritated bladders.
Cystometrograms during saline or 0.2% AA infusion were recorded under urethane anesthesia in female Sprague-Dawley rats. After a stabilization period, CCPA (A1 receptor agonist) and/or ZM24138 (A2A receptor antagonist) were administered intravenously (i.v.), intrathecally (i.t.), intracerebroventricularly (i.c.v.), or intravesically. Micturition parameters were recorded and compared before and after drug administration.
I.v., i.t., or i.c.v. administration of CCPA or ZM24138 significantly increased intercontraction intervals (ICIs) in both saline and AA infusion groups. During AA infusion, the inhibitory effects induced by i.c.v. CCPA or i.t. ZM24138 were significantly greater than those by i.t. or i.c.v. administration, respectively. Intravesical administration of CCPA, but not ZM24138, significantly increased ICI.
These results indicated that: (1) when nociceptive signals from the bladder increase, adenosine A1 receptor-mediated inhibition of micturition is enhanced in the brain, compared to the normal condition, (2) A1 receptor activation also exerts a peripheral inhibitory effect on micturition, and (3) adenosine A2A receptor-mediated excitatory mechanisms are enhanced in the spinal cord following C-fiber bladder afferent stimulation. Thus adenosine A1 receptor agonists and A2A receptor antagonists might be effective for the treatment of overactive bladder and/or bladder hypersensitive disorders, in which C-fiber afferent function is enhanced.
腺苷是一种神经递质,在许多器官中发挥多种生理作用。然而,很少有研究关注腺苷受体在排尿控制中的作用。因此,我们研究了腺苷A1和A2A受体在正常或乙酸(AA)刺激膀胱的大鼠膀胱活动控制中的作用。
在乌拉坦麻醉下,记录雌性Sprague-Dawley大鼠在输注生理盐水或0.2% AA期间的膀胱压力图。在稳定期后,静脉内(i.v.)、鞘内(i.t.)、脑室内(i.c.v.)或膀胱内给予CCPA(A1受体激动剂)和/或ZM24138(A2A受体拮抗剂)。记录给药前后的排尿参数并进行比较。
静脉内、鞘内或脑室内给予CCPA或ZM24138均显著增加了生理盐水和AA输注组的收缩间期(ICIs)。在AA输注期间,脑室内CCPA或鞘内ZM24138诱导的抑制作用分别显著大于鞘内或脑室内给药诱导的抑制作用。膀胱内给予CCPA可显著增加ICI,但给予ZM24138则无此作用。
这些结果表明:(1)当膀胱的伤害性信号增加时,与正常情况相比,腺苷A1受体介导的排尿抑制在大脑中增强;(2)A1受体激活也对排尿产生外周抑制作用;(3)在C纤维膀胱传入刺激后,腺苷A2A受体介导的兴奋机制在脊髓中增强。因此,腺苷A1受体激动剂和A2A受体拮抗剂可能对治疗膀胱过度活动症和/或膀胱过敏症有效,在这些疾病中C纤维传入功能增强。